By Professor Herbert Herzog

Journal articles

Khor EC; Fanshawe B; Qi Y; Zolotukhin S; Kulkarni RN; Enriquez RF; Purtell L; Lee NJ; Wee NK; Croucher PI; Campbell L; Herzog H; Baldock PA, 2016, 'Prader-willi critical region, a non-translated, imprinted central regulator of bone mass: Possible role in skeletal abnormalities in Prader-Willi Syndrome', PLoS ONE, 11, pp. e0148155, http://dx.doi.org/10.1371/journal.pone.0148155

Lengkeek NA; Roberts MP; Zhang L; Lee ICJ; Fookes CJR; Dikic B; Herzog H; Katsifis A; Greguric I, 2016, 'Synthesis and Binding Affinity of Fluorine Containing N^G-acyl and -sulfonyl BIBP3226 Derivatives: Ligands for the NPY Y1 Receptor', Australian Journal of Chemistry, 69, pp. 746 - 752, http://dx.doi.org/10.1071/CH15569

Lau J; Mietzsch M; Heilbronn R; Herzog H, 2016, 'CART's suppressive effects on appetite are controlled by NPY signaling', Neuropeptides, 55, pp. 30 - 30, http://dx.doi.org/10.1016/j.npep.2015.11.085

Mountford S; Liu O; Zhang L; Richardson R; Groenen M; Herzog H; Holliday N; Thompson P, 2016, 'Developing superior peptide conjugates for studying Y receptor biology', Neuropeptides, 55, pp. 10 - 10, http://dx.doi.org/10.1016/j.npep.2015.11.024

Tasan RO; Verma D; Wood J; Lach G; Hörmer B; Mäde V; Beck-Sickinger AG; Herzog H; Sperk G, 2016, 'Hunger promotes fear extinction by activation of an amygdala microcircuit', Neuropeptides, 55, pp. 19 - 20, http://dx.doi.org/10.1016/j.npep.2015.11.054

Zhang L; Lee I-CJ; Herzog H, 2016, 'Hypothalamic neuropeptide FF receptor-2 signaling is critical for the regulation of energy homeostasis', Neuropeptides, 55, pp. 13 - 13, http://dx.doi.org/10.1016/j.npep.2015.11.034

Tough IR; Herzog H; Cox HM, 2016, 'Inducible upregulation of PYY in adult mice increases efficacy of inhibitory GPR119, MC4, FFAR1 and FFAR4 responses in distal colon', Neuropeptides, 55, pp. 26 - 26, http://dx.doi.org/10.1016/j.npep.2015.11.074

Reichmann F; Hassan AM; Herzog H; Holzer P, 2016, 'Neuropeptide Y participates in anxiolysis due to environmental enrichment', Neuropeptides, 55, pp. 22 - 23, http://dx.doi.org/10.1016/j.npep.2015.11.063

Hörmer BA; Verma D; Gasser E; Herzog H; Tasan RO, 2016, 'NPY and Y2R in adult neurogenesis and fear learning', Neuropeptides, 55, pp. 22 - 22, http://dx.doi.org/10.1016/j.npep.2015.11.061

Herzog H, 2016, 'NPY pathways that control the brain-bone-pancreas triangle', Neuropeptides, 55, pp. 29 - 29, http://dx.doi.org/10.1016/j.npep.2015.11.083

Wood J; Verma D; Herzog H; Sperk G; Tasan R, 2016, 'NPY Y2 receptor reduces excitatory and inhibitory synaptic transmission in the centromedial amygdala', Neuropeptides, 55, pp. 4 - 4, http://dx.doi.org/10.1016/j.npep.2015.11.008

Verma D; Tasan RO; Herzog H; Sperk G; Pape H-C, 2016, 'Pathways and mechanisms of NPY and Y2 receptors for controlling conditioned fear', Neuropeptides, 55, pp. 22 - 22, http://dx.doi.org/10.1016/j.npep.2015.11.062

Baldock PA; Lee NJ; Laybutt R; Herzog H, 2016, 'The role of NPY in obesity-induced bone loss', Neuropeptides, 55, pp. 7 - 7, http://dx.doi.org/10.1016/j.npep.2015.11.016

Khor E-C; Yulyaningsih E; Lee NJ; Driessler F; Kovaĉić N; Wee NKY; Kulkarni RN; Enriquez RF; Xu J; Zhang L; Herzog H; Baldock PA, 2016, 'The y6 receptor suppresses bone resorption and stimulates bone formation in mice', Neuropeptides, 55, pp. 24 - 24, http://dx.doi.org/10.1016/j.npep.2015.11.068

Verma D; Wood J; Lach G; Mietzsch M; Weger S; Heilbronn R; Herzog H; Bonaventure P; Sperk G; Tasan RO, 2015, 'NPY Y2 receptors in the central amygdala reduce cued but not contextual fear', Neuropharmacology, 99, pp. 665 - 674, http://dx.doi.org/10.1016/j.neuropharm.2015.08.038

Zieba J; Low JK; Purtell L; Qi Y; Campbell L; Herzog H; Karl T, 2015, 'Behavioural characteristics of the Prader-Willi syndrome related biallelic Snord116 mouse model', Neuropeptides, 53, pp. 71 - 77, http://dx.doi.org/10.1016/j.npep.2015.06.009

Shi YC; Loh K; Bensellam M; Lee K; Zhai L; Lau J; Cantley J; Luzuriaga J; Laybutt DR; Herzog H, 2015, 'Pancreatic PYY is critical in the control of insulin secretion and glucose homeostasis in female mice', Endocrinology (United States), 156, pp. 3122 - 3136, http://dx.doi.org/10.1210/en.2015-1168

Qi Y; Fu M; Herzog H, 2015, 'Y2 receptor signalling in NPY neurons controls bone formation and fasting induced feeding but not spontaneous feeding', Neuropeptides, http://dx.doi.org/10.1016/j.npep.2015.09.009

Tasan RO; Verma D; Wood J; Lach G; Hörmer B; de Lima TCM; Herzog H; Sperk G, 2015, 'The role of Neuropeptide Y in fear conditioning and extinction', Neuropeptides, http://dx.doi.org/10.1016/j.npep.2015.09.007

Tsai VWW; Macia L; Feinle-Bisset C; Manandhar R; Astrup A; Raben A; Lorenzen JK; Schmidt PT; Wiklund F; Pedersen NL; Campbell L; Kriketos A; Xu A; Pengcheng Z; Jia W; Curmi PMG; Angstmann CN; Lee-Ng KKM; Zhang HP; Marquis CP; Husaini Y; Beglinger C; Lin S; Herzog H; Brown DA; Sainsbury A; Breit SN; Lee-Ng M, 2015, 'Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMI', PLoS ONE, 10, pp. e0133362, http://dx.doi.org/10.1371/journal.pone.0133362

Park MH; Jin HK; Min WK; Lee WW; Lee JE; Akiyama H; Herzog H; Enikolopov GN; Schuchman EH; Bae JS, 2015, 'Neuropeptide Y regulates the hematopoietic stem cell microenvironment and prevents nerve injury in the bone marrow', EMBO Journal, 34, pp. 1648 - 1660, http://dx.doi.org/10.15252/embj.201490174

Purtell L; Viardot A; Sze L; Loughnan G; Steinbeck K; Sainsbury A; Herzog H; Smith A; Campbell LV, 2015, 'Postprandial metabolism in adults with prader-willi syndrome', Obesity, 23, pp. 1159 - 1165, http://dx.doi.org/10.1002/oby.21041

Lee NJ; Nguyen AD; Enriquez RF; Luzuriaga J; Bensellam M; Laybutt R; Baldock PA; Herzog H; Laybutt D, 2015, 'NPY signalling in early osteoblasts controls glucose homeostasis', Molecular Metabolism, 4, pp. 164 - 174, http://dx.doi.org/10.1016/j.molmet.2014.12.010

Loh K; Herzog H; Shi YC, 2015, 'Regulation of energy homeostasis by the NPY system', Trends in Endocrinology and Metabolism, 26, pp. 125 - 135, http://dx.doi.org/10.1016/j.tem.2015.01.003

Northfield SE; Mountford SJ; Wielens J; Liu M; Zhang L; Herzog H; Holliday ND; Scanlon MJ; Parker MW; Chalmers DK; Thompson PE, 2015, 'Propargyloxyproline Regio- and Stereoisomers for Click-Conjugation of Peptides: Synthesis and Application in Linear and Cyclic Peptides', Australian Journal of Chemistry, 68, pp. 1365 - 1372, http://dx.doi.org/10.1071/CH15146

Qi Y; Inoue K; Fu M; Inui A; Herzog H, 2014, 'Chronic overproduction of ghrelin in the hypothalamus leads to temporal increase in food intake and body weight', Neuropeptides, 50, pp. 23 - 28, http://dx.doi.org/10.1016/j.npep.2015.02.002

Huang L; Tan HY; Fogarty MJ; Andrews ZB; Veldhuis JD; Herzog H; Steyn FJ; Chen C, 2014, 'Actions of NPY, and its Y1 and Y2 receptors on pulsatile growth hormone secretion during the fed and fasted state', Journal of Neuroscience, 34, pp. 16309 - 16319, http://dx.doi.org/10.1523/JNEUROSCI.4622-13.2014

Baldock PA; Lin S; Zhang L; Karl T; Shi Y; Driessler F; Zengin A; Hörmer B; Lee NJ; Wong IPL; Lin EJD; Enriquez RF; Stehrer B; During MJ; Yulyaningsih E; Zolotukhin S; Ruohonen ST; Savontaus E; Sainsbury A; Herzog H, 2014, 'Neuropeptide Y attenuates stress-induced bone loss through suppression of noradrenaline circuits', Journal of Bone and Mineral Research, 29, pp. 2238 - 2249, http://dx.doi.org/10.1002/jbmr.2205

Sousa DM; Baldock PA; Enriquez RE; Lamghari M; Herzog H, 2014, 'Neuropeptide Y Y-1 receptor antagonism: a novel anabolic tool for bone regeneration', JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE, 8, pp. 81 - 82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000337612600148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mountford SJ; Liu M; Zhang L; Groenen M; Herzog H; Holliday ND; Thompson PE, 2014, 'Synthetic routes to the Neuropeptide y Y1 receptor antagonist 1229U91 and related analogues for SAR studies and cell-based imaging', Organic and Biomolecular Chemistry, 12, pp. 3271 - 3281, http://dx.doi.org/10.1039/c4ob00176a

Sousa DM; McDonald MM; Mikulec K; Peacock L; Little DG; Herzog H; Lamghari M; Baldock PA, 2014, 'The role of neuropeptide Y Y1 receptor signalling in fracture healing', Bone Abstracts, http://dx.doi.org/10.1530/boneabs.3.oc1.6

Yulyaningsih E; Loh K; Lin S; Lau J; Zhang L; Shi Y; Berning BA; Enriquez R; Driessler F; Macia L; Khor EC; Qi Y; Baldock P; Sainsbury A; Herzog H, 2014, 'Pancreatic polypeptide controls energy homeostasis via Npy6r signaling in the suprachiasmatic nucleus in mice', Cell Metabolism, 19, pp. 58 - 72, http://dx.doi.org/10.1016/j.cmet.2013.11.019

Lau J; Herzog H, 2014, 'CART in the regulation of appetite and energy homeostasis', Frontiers in Neuroscience, 8, http://dx.doi.org/10.3389/fnins.2014.00313

Nguyen AD; Slack K; Schwarzer C; Lee NJ; Boey D; Macia L; Yulyaningsih E; Enriquez RF; Zhang L; Lin S; Shi YC; Baldock PA; Herzog H; Sainsbury A, 2014, 'Double deletion of orexigenic neuropeptide Y and dynorphin results in paradoxical obesity in mice', Neuropeptides, 48, pp. 143 - 151, http://dx.doi.org/10.1016/j.npep.2014.03.001

Zhang L; Lee ICJ; Enriquez RF; Lau J; Vähätalo LH; Baldock PA; Savontaus E; Herzog H, 2014, 'Stress- and diet-induced fat gain is controlled by NPY in catecholaminergic neurons', Molecular Metabolism, 3, pp. 581 - 591, http://dx.doi.org/10.1016/j.molmet.2014.05.001

Herzog H, 2014, 'Hypothalamic pathways for energy intake and expenditure including recent insights into circadian cycles', Obesity Research & Clinical Practice, 8, pp. 45 - 45, http://dx.doi.org/10.1016/j.orcp.2014.10.083

Tsai VW-W; Macia L; Manandhar R; Wiklund F; Grönberg H; Pedersen N; Lee-Ng M; Zhang HP; Brown D; Herzog H; Sainsbury A; Breit SN, 2014, 'Macrophage inhibitory cytokine 1 (MIC-1/GDF15), a novel regulator of body weight and appetite and a potential therapeutic for obesity', Obesity Research & Clinical Practice, 8, pp. 105 - 105, http://dx.doi.org/10.1016/j.orcp.2014.10.191

Menard C; Cavanagh C; Tse YC; Chabot J; Herzog H; Schwarzer C; Ferland G; Quirion R; Wong TP; Gaudreau P, 2014, 'O4‐09‐03: LOW HIPPOCAMPAL PRODYNORPHIN LEVELS ARE ASSOCIATED WITH MAINTENANCE OF MEMORY IN VARIOUS AGING RODENT MODELS', Alzheimer's & Dementia, 10, http://dx.doi.org/10.1016/j.jalz.2014.04.435

Huang L; Tan H; Fogarty M; Stark R; Andrews Z; Veldhuis J; Herzog H; Chen C; Steyn F, 2014, 'OR3-5: NPY neurons as a critical hypothalamic node for the control of GH release relative to food intake', Growth Hormone & IGF Research, 24, pp. S11 - S11, http://dx.doi.org/10.1016/s1096-6374(14)50027-5

Ménard C; Herzog H; Schwarzer C; Quirion R, 2014, 'Possible Role of Dynorphins in Alzheimer's Disease and Age-Related Cognitive Deficits', Neurodegenerative Diseases, 13, pp. 82 - 85, http://dx.doi.org/10.1159/000353848

Sala MSL; Hurtado MD; Brown AR; Bohórquez DV; Liddle RA; Herzog H; Zolotukhin S; Dotson CD, 2013, 'Modulation of taste responsiveness by the satiation hormone peptide YY', FASEB Journal, 27, pp. 5022 - 5033, http://dx.doi.org/10.1096/fj.13-228064

Shi YC; Lin Z; Lau J; Zhang H; Yagi M; Kanzler I; Sainsbury A; Herzog H; Lin S, 2013, 'PYY3-36 and pancreatic polypeptide reduce food intake in an additive manner via distinct hypothalamic dependent pathways in mice', Obesity, 21, http://dx.doi.org/10.1002/oby.20534

Hurtado MD; Sergeyev VG; Acosta A; Spegele M; La Sala M; Waler NJ; Chiriboga-Hurtado J; Currlin SW; Herzog H; Dotson CD; Gorbatyuk OS; Zolotukhin S, 2013, 'Salivary peptide tyrosine-tyrosine 3-36 modulates ingestive behavior without inducing taste aversion', Journal of Neuroscience, 33, pp. 18368 - 18380, http://dx.doi.org/10.1523/JNEUROSCI.1064-13.2013

Painsipp E; Köfer MJ; Farzi A; Dischinger US; Sinner F; Herzog H; Holzer P, 2013, 'Neuropeptide y and peptide YY protect from weight loss caused by Bacille Calmette-Guérin in mice', British Journal of Pharmacology, 170, pp. 1014 - 1026, http://dx.doi.org/10.1111/bph.12354

Sousa DM; McDonald MM; Mikulec K; Peacock L; Herzog H; Lamghari M; Little DG; Baldock PA, 2013, 'Neuropeptide y modulates fracture healing through Y1 receptor signaling', Journal of Orthopaedic Research, 31, pp. 1570 - 1578, http://dx.doi.org/10.1002/jor.22400

Purtell L; Herzog H, 2013, 'PYY', , pp. 1307 - 1313, http://dx.doi.org/10.1016/B978-0-12-385095-9.00178-0

Shi YC; Lau J; Lin Z; Zhang H; Zhai L; Sperk G; Heilbronn R; Mietzsch M; Weger S; Huang XF; Enriquez R; Castillo L; Baldock P; Zhang L; Sainsbury A; Herzog H; Lin S, 2013, 'Erratum: Arcuate NPY controls sympathetic output and BAT function via a relay of tyrosine hydroxylase neurons in the PVN (Cell Metabolism 17 (236-248))', Cell Metabolism, 18, pp. 144, http://dx.doi.org/10.1016/j.cmet.2013.06.012

Romero-Picó A; Vázquez MJ; González-Touceda D; Folgueira C; Skibicka KP; Alvarez-Crespo M; Van Gestel MA; Velásquez DA; Schwarzer C; Herzog H; López M; Adan RA; Dickson SL; Diéguez C; Nogueiras R, 2013, 'Hypothalamic κ-opioid receptor modulates the orexigenic effect of ghrelin', Neuropsychopharmacology, 38, pp. 1296 - 1307, http://dx.doi.org/10.1038/npp.2013.28

Bervini S; Herzog H, 2013, 'Mouse models of Prader-Willi Syndrome: A systematic review', Frontiers in Neuroendocrinology, 34, pp. 107 - 119, http://dx.doi.org/10.1016/j.yfrne.2013.01.002

Liu M; Mountford SJ; Zhang L; Lee IC; Herzog H; Thompson PE, 2013, 'Synthesis of BVD15 peptide analogues as models for radioligands in tumour imaging', International Journal of Peptide Research and Therapeutics, 19, pp. 33 - 41, http://dx.doi.org/10.1007/s10989-012-9330-z

Back to profile page